Germline hMLH1 promoter mutation in a Newfoundland HNPCC kindred

被引:20
作者
Green, RC [1 ]
Green, AG
Simms, M
Pater, A
Robb, JD
Green, JS
机构
[1] Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, Discipline Genet, St Johns, NF A1B 3V6, Canada
[2] Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St Johns, NF A1B 3V6, Canada
[3] Mem Univ Newfoundland, Fac Med, Discipline Lab Med, St Johns, NF A1B 3V6, Canada
关键词
hereditary non-polyposis colon cancer; hMLH1; promoter; mutation; Myb;
D O I
10.1034/j.1399-0004.2003.t01-1-00110.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary non-polyposis colon cancer (HNPCC) is an autosomal dominant form of inherited predisposition to colorectal and other malignancies. It is associated with mutations in DNA mismatch-repair genes, especially hMSH2 and hMLH1. Management of HNPCC families is improved if the underlying mutation in each family can be discovered. We describe a Newfoundland kindred, meeting the Amsterdam Criteria for HNPCC, in which a mutation in the promoter region of the hMLH1 gene co-segregates with the disease phenotype. The -42C > T mutation is within a putative Myb proto-oncogene binding site. Using electrophoretic mobility shift assays, we demonstrated that the mutated Myb binding sequence is less effective in binding nuclear proteins than the wild-type promoter sequence. Using in vivo transfection experiments in HeLa cells, we further demonstrated that the mutated promoter has only 37% of the activity of the wild-type promoter in driving the expression of a reporter gene. The average age of onset in six family members affected with colorectal cancer is 62 years, which is substantially later than the typical age of onset in HNPCC families. This is consistent with a substantial decrease, but not total elimination, of mismatch repair function in affected members of this family. This is the first report of a heritable hMLH1 promoter mutation in any HNPCC family.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 32 条
  • [1] BURT RW, 1995, ANNU REV MED, V46, P371
  • [2] Charbonnier F, 2000, CANCER RES, V60, P2760
  • [3] The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas
    Cunningham, JM
    Kim, CY
    Christensen, ER
    Tester, DJ
    Parc, Y
    Burgart, LJ
    Halling, KC
    McDonnell, SK
    Schaid, DJ
    Vockley, CW
    Kubly, V
    Nelson, H
    Michels, VV
    Thibodeau, SN
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 780 - 790
  • [4] Curia MC, 1999, CANCER RES, V59, P3570
  • [5] Binding site analysis of c-Myb: Screening of potential binding sites by using the mutation matrix derived from systematic binding affinity measurements
    Deng, QL
    Ishii, S
    Sarai, A
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (04) : 766 - 774
  • [6] Funato T, 2001, ONCOL REP, V8, P807
  • [7] Myb targeted therapeutics for the treatment of human malignancies
    Gewirtz, AM
    [J]. ONCOGENE, 1999, 18 (19) : 3056 - 3062
  • [8] Heinimann K, 1999, CANCER, V85, P2512, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2512::AID-CNCR4>3.0.CO
  • [9] 2-G
  • [10] A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1
    Ito, E
    Yanagisawa, Y
    Iwahashi, Y
    Suzuki, Y
    Nagasaki, H
    Akiyama, Y
    Sugano, S
    Yuasa, Y
    Maruyama, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (03) : 488 - 494